Albert J. Robichaud
2021
Compensation breakdown
| Non-Equity Incentive Plan | $192,218 |
|---|---|
| Option Awards | $1,208,940 |
| Salary | $457,660 |
| Stock Awards | $925,538 |
| Other | $11,806 |
| Total | $2,796,162 |
Robichaud received $1.2M in option awards, accounting for 43% of the total pay in 2021.
Robichaud also received $192.2K in non-equity incentive plan, $457.7K in salary, $925.5K in stock awards and $11.8K in other compensation.
Rankings
In 2021, Albert J. Robichaud's compensation ranked 4,708th out of 12,415 executives tracked by ExecPay. In other words, Robichaud earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,708 out of 12,415 | 62nd |
Division Manufacturing | 1,959 out of 5,505 | 64th |
Major group Chemicals And Allied Products | 821 out of 2,375 | 65th |
Industry group Drugs | 734 out of 2,096 | 65th |
Industry Pharmaceutical Preparations | 523 out of 1,546 | 66th |
Pay ratio
| Albert J. Robichaud's Pay | $2,796,162 |
|---|---|
| Median Employee's Pay | $308,210 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Albert J. Robichaud was $2,796,162.
The annual total compensation of the median employee at Sage Therapeutics was $308,210.
The ratio of Albert J. Robichaud's pay to the pay of median employee was therefore 9 to one.
Robichaud's colleagues
We found four more compensation records of executives who worked with Albert J. Robichaud at Sage Therapeutics in 2021.
News
April 28, 2022
April 29, 2021
April 29, 2020
April 25, 2019